BSE Live
Jan 29, 16:01Prev. Close
1435.00
Open Price
1447.20
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Jan 29, 15:50Prev. Close
1436.20
Open Price
1446.10
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Hester Biosciences (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 5.19 | 5.19 | 5.19 | 5.19 | 3.71 | |
| Total Share Capital | 5.19 | 5.19 | 5.19 | 5.19 | 3.71 | |
| Reserves and Surplus | 35.67 | 31.46 | 28.28 | 22.76 | 9.94 | |
| Total Reserves and Surplus | 35.67 | 31.46 | 28.28 | 22.76 | 9.94 | |
| Total Shareholders Funds | 40.86 | 36.65 | 33.47 | 27.95 | 13.65 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 8.28 | 10.94 | 13.81 | 10.31 | 0.44 | |
| Deferred Tax Liabilities [Net] | 2.70 | 2.62 | 1.90 | 1.68 | 0.87 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 10.98 | 13.55 | 15.70 | 11.99 | 1.31 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 11.87 | 7.83 | 6.33 | 12.05 | 1.26 | |
| Trade Payables | 1.61 | 2.61 | 1.49 | 2.31 | 0.62 | |
| Other Current Liabilities | 2.32 | 2.31 | 2.04 | 3.68 | 0.65 | |
| Short Term Provisions | 13.34 | 14.21 | 11.50 | 7.55 | 4.99 | |
| Total Current Liabilities | 29.15 | 26.96 | 21.37 | 25.58 | 7.51 | |
| Total Capital And Liabilities | 80.99 | 77.16 | 70.54 | 65.52 | 22.47 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 39.84 | 40.53 | 40.90 | 34.88 | 4.65 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 0.00 | 0.00 | 0.00 | 0.55 | 2.32 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 39.84 | 40.53 | 40.90 | 35.43 | 6.97 | |
| Non-Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Deferred Tax Assets [Net] | 0.05 | 0.03 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.08 | |
| Total Non-Current Assets | 39.88 | 40.56 | 40.90 | 35.43 | 7.05 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 16.96 | 11.71 | 7.01 | 4.99 | 2.75 | |
| Trade Receivables | 11.02 | 12.34 | 10.59 | 9.67 | 8.47 | |
| Cash And Cash Equivalents | 0.96 | 0.65 | 0.65 | 6.88 | 0.17 | |
| Short Term Loans And Advances | 12.17 | 11.91 | 11.38 | 8.54 | 4.02 | |
| OtherCurrentAssets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Current Assets | 41.11 | 36.60 | 29.63 | 30.09 | 15.42 | |
| Total Assets | 80.99 | 77.16 | 70.54 | 65.52 | 22.47 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 0.46 | 0.35 | 0.51 | 2.83 | 0.00 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 2.94 | 2.56 | 3.30 | 4.33 | 1.11 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.26 | 2.76 | 0.70 | 3.39 | 1.82 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | 0.78 | 0.67 | 0.70 | 0.20 | 0.32 | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | -- | -- | -- | -- | -- | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
19.11.2025
Hester Bio Consolidated September 2025 Net Sales at Rs 70.97 crore, down 15.2% Y-o-Y
18.11.2025
Hester Bio Standalone September 2025 Net Sales at Rs 64.58 crore, down 12.14% Y-o-Y
01.08.2025
Hester Bio Standalone June 2025 Net Sales at Rs 63.49 crore, down 13.58% Y-o-Y
09.05.2025
Hester Bio Standalone March 2025 Net Sales at Rs 76.67 crore, up 5.21% Y-o-Y
19.11.2025
Hester Bio Consolidated September 2025 Net Sales at Rs 70.97 crore, down 15.2% Y-o-Y
18.11.2025
Hester Bio Standalone September 2025 Net Sales at Rs 64.58 crore, down 12.14% Y-o-Y
01.08.2025
Hester Bio Standalone June 2025 Net Sales at Rs 63.49 crore, down 13.58% Y-o-Y
09.05.2025
Hester Bio Standalone March 2025 Net Sales at Rs 76.67 crore, up 5.21% Y-o-Y